Patents by Inventor Brian Thomas Campbell

Brian Thomas Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR HEALTH DATA VISUALIZATION AND USER SUPPORT TOOLS FOR CONTINUOUS GLUCOSE MONITORING
    Publication number: 20240115211
    Abstract: Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.
    Type: Application
    Filed: December 19, 2023
    Publication date: April 11, 2024
    Inventors: Esteban CABRERA, JR., Lauren Danielle ARMENTA, Scott M. BELLIVEAU, Jennifer BLACKWELL, Leif N. BOWMAN, Rian DRAEGER, Arturo GARCIA, Timothy Joseph GOLDSMITH, John Michael GRAY, Andrea Jean JACKSON, Apurv Ullas KAMATH, Katherine Yerre KOEHLER, Paul KRAMER, Aditya Sagar MANDAPAKA, Michael Robert MENSINGER, Sumitaka MIKAMI, Gary A. MORRIS, Hemant Mahendra NIRMAL, Paul NOBLE-CAMPBELL, Philip Thomas PUPA, Eli REIHMAN, Peter C. SIMPSON, Brian Christopher SMITH, Atiim Joseph WILEY
  • Systems and methods for health data visualization and user support tools for continuous glucose monitoring
    Patent number: 11931188
    Abstract: Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: March 19, 2024
    Assignee: Dexcom, Inc.
    Inventors: Esteban Cabrera, Jr., Lauren Danielle Armenta, Scott M. Belliveau, Jennifer Blackwell, Leif N. Bowman, Rian Draeger, Arturo Garcia, Timothy Joseph Goldsmith, John Michael Gray, Andrea Jean Jackson, Apurv Ullas Kamath, Katherine Yerre Koehler, Paul Kramer, Aditya Sagar Mandapaka, Michael Robert Mensinger, Sumitaka Mikami, Gary A Morris, Hemant Mahendra Nirmal, Paul Noble-Campbell, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Brian Christopher Smith, Atiim Joseph Wiley
  • Treatment of neuropathic pain with 6-pyrrolo[3,4-]pyridazine compounds
    Patent number: 7465730
    Abstract: 6H-pyrrolo[3,4-d]pyridazine compounds and methods of their use of as ligands of voltage gated calcium channels (VGCC), useful in the treatment of neuropathic pain, and psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal and other.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: December 16, 2008
    Assignee: Merck & Co. Inc.
    Inventors: Naomi Burke Anker, Jeannie M. Arruda, Brian Thomas Campbell, Benito Munoz, Petpiboon Prasit, Brian A. Stearns, Tao Hu
  • Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
    Patent number: 7105533
    Abstract: Phenyl compounds substituted with a fused-heterobicyclo moiety, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: September 12, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Brian Thomas Campbell, Janet Lorraine Gunzer, Benito Munoz, Brian Andrew Stearns, Jean-Michel Andre Vernier, Bowei Wang